Anonymous ID: 17c58f Feb. 3, 2022, 2:54 a.m. No.15534713   🗄️.is 🔗kun   >>4726 >>4734 >>4735 >>4737 >>4776 >>4823 >>5137

>>15534637

If Anons want a DEEP dig about Nanotechnology in the vaccine AND testing swabs…

dig into Ming Hsieh

-He and his family have ties to CCP

-He is (now) an American billionaire

-He studied Computer Engineering at USC and now has a Department named after him.

-He founded Fulgent technologies

-He developed digital thumbprint technology and has many contracts with US government

-He developed Nanotechnology

-He developed the way to break through the Blood Brain Barrier to insert Nanotechnology, using lipids on swabs, into the brain. (Under the guise of med research) Think CoVid testing

BBB- blood brain barrier

BBB- build back better

 

The list goes on and on…

Here’s a start of sauce. There is so much moar.

 

https://minghsiehece.usc.edu/

 

https://www.corporationwiki.com/California/Los-Angeles/ming-hsieh/44284209.aspx

 

https://americanhistory.si.edu/family-voices/individuals/ming-hsieh

 

https://mhicancer.usc.edu/ming-hsieh/

 

https://forensics.wvu.edu/faculty-and-staff/faculty/keith-morris

 

https://sfi.usc.edu/news/2015/10/10294-usc-shoah-foundation-delegation-attends-usc-global-conference-china

 

https://www.sec.gov/Archives/edgar/data/1289434/000118143110050562/xslF345X03/rrd288148.xml

 

http://wvutoday-archive.wvu.edu/n/2014/05/21/entrepreneur-ming-hsieh-donates-250k-to-wvu-forensics-program.html

 

http://wvutoday-archive.wvu.edu/n/2014/05/21/entrepreneur-ming-hsieh-donates-250k-to-wvu-forensics-program.html

 

https://www.fool.com/investing/2021/04/20/fulgent-genetics-ceo-just-told-investors-to-look-o/

 

https://labusinessjournal.com/news/2020/aug/05/fulgent-genetics-earnings-soar-covid-testing/

 

https://eintaxid.com/company/812621304-fulgent-genetics%2C-inc./

 

https://www.superyachtfan.com/yacht/ocean-dreamwalker/

Anonymous ID: 17c58f Feb. 3, 2022, 3:22 a.m. No.15534776   🗄️.is 🔗kun   >>4789 >>4794

>>15534713

University of Southern California

Ming Hsieh

Department of Electrical and Computer Engineering

Navigation

Cutting Edge Examples of Medical Device-on-a-Chip

 

Maysam Ghovanloo, PhD

 

GT-Bionics Lab, School of Electrical and Computer Engineering

Georgia Institute of Technology

 

https://minghsiehece.usc.edu/2018/04/cutting-edge-examples-of-medical-device-on-a-chip/

Anonymous ID: 17c58f Feb. 3, 2022, 3:27 a.m. No.15534789   🗄️.is 🔗kun   >>4794

>>15534776

Maysam Ghovanloo received the B.S. degree in electrical engineering from the University of Tehran in 1994, and the =M.S. degree in biomedical engineering from the Amirkabir University of Technology, Tehran, Iran in 1997.== He also received the M.S. and Ph.D. degrees in electrical engineering from the University of Michigan, Ann Arbor, in 2003 and 2004, respectively.

 

Dr. Ghovanloo developed the first modular Patient Care Monitoring System in Iran and started a company to manufacture research instruments for electrophysiology and pharmacology labs. From 2004 to 2007 he was an assistant professor in the Department of ECE at theNorth Carolina State University, Raleigh, NC.Since 2007 he has been with the Georgia Tech’s School of Electrical and Computer Engineering, where he is a professor and the founding director of the GT-Bionics Lab. In 2012 he started Bionic Sciences Inc., a technology transfer company, where he serves as the CTO. He has authored or coauthored more than 200 peer-reviewed conference and journal publications on implantable microelectronic devices, integrated circuits and microsystems for medical applications, and modern assistive/rehabilitation technologies. He also holds 8 issued patents.

Anonymous ID: 17c58f Feb. 3, 2022, 3:28 a.m. No.15534794   🗄️.is 🔗kun

>>15534776

>>15534789

 

For medical devices that need to be implanted or positioned inside the human body to deliver a therapy,size and functionality are among the most important parameters, affecting key aspects of the device, such as feasibility, level of invasiveness, side effects, and safety, ability to reach the desired anatomical target, and efficacy in carrying out intended functions, such as imaging, recording biological parameters, delivering drugs, or applying stimuli, or a combination of these as part of a medical intervention. on the On the other hand, microelectronic devices, integrated circuit design, and system-level architectures have advanced to the point that combining multiple functions in a variety of domains from low noise analog readout, to on-chip digital processing, RF connectivity, power management, and precise control of physical outputs on a monolithic piece of silicon has become quite routine, in an approach referred to as the system-on-a-chip (SoC). In this talk, I will present a few examples of applying the well-established SoC technology towards design and development of cutting edge medical devices that are fit to be implanted or delivered inside the body, while being supported by system blocks outside of the body, to either create de novo medical interventions or significantly improve the existing therapies. I refer to these as the medical device-on-a-chip (MDoC) approach, and also propose the pathway towards design concept, preliminary steps, and evaluation plans for new MDoC technologies that would enable new therapies and interventions that are not feasible today.

Anonymous ID: 17c58f Feb. 3, 2022, 3:37 a.m. No.15534804   🗄️.is 🔗kun

>>15534770

>Fulgent & Cogent

 

Fulgent Genetics' (NASDAQ:FLGT) CEO Ming Hsieh made one of these on the company's fourth quarter call in March. He mentioned the potential for an acquisition to expand the company's diagnostic and screening capabilities. Further, he specifically called out a desire to open up new markets in Asia and Europe. With those two pieces of information, let's explore a few of the companies Fulgent Genetics might buy.

 

Men at work

Ming Hsieh has some experience making deals. He came to the U.S. as an engineering student at the University of Southern California and founded a company directly out of school. Then he founded another. The second, Cogent Systems, developed fingerprint identification technology and was sold to 3M for $943 million in 2010. A year later, he founded Fulgent Genetics. Several of the C-level executives currently at Fulgent were also with him at Cogent.

 

Prior to the COVID-19 pandemic, the company's business was primarily reproductive testing, as well as testing for cancer and rare diseases.Its early entry into COVID testing propelled revenue to $422 million last year, a 1200% climb from the prior year.With business still booming, Hsieh shared that it had $625 million in cash at the end of February. That's plenty of money to go shopping for an acquisition in a fragmented industry.

 

https://www.fool.com/investing/2021/04/20/fulgent-genetics-ceo-just-told-investors-to-look-o/

 

Wonder which companies he bought?

Anonymous ID: 17c58f Feb. 3, 2022, 3:51 a.m. No.15534837   🗄️.is 🔗kun   >>4839

>>15534805

 

>CNN

>vid cap

>The Masked Singer.

>Rudy Guiliani "Unmasked" on March 9th.

 

4235

Q !!Hs1Jq13jV6 05/13/2020 20:18:52 ID: 1a3e4f

Archive Bread/Post Links: 9161007 / 9161693

Direct Link: 9161693

The point to understand.

They [knowingly]unmasked[attached names to] AFTER POTUS won the election of 2016.

They thought they could prevent the exposure of this information and remain protected.

Why did they believe this?

What 'insurance' did they have?

Infiltration of US GOV?

This fact alone should scare every American.

SHADOW PRESIDENCY.

SHADOW GOVERNMENT.

It took this long for a reason.

Q